NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 23 filers reported holding NEUROPACE INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,186,440 | -35.1% | 686,037 | +13.3% | 0.00% | -33.3% |
| Q1 2024 | $7,995,412 | +349.8% | 605,713 | +251.3% | 0.00% | +200.0% |
| Q4 2023 | $1,777,475 | -0.8% | 172,403 | -6.4% | 0.00% | 0.0% |
| Q3 2023 | $1,791,964 | -36.5% | 184,169 | -70.7% | 0.00% | 0.0% |
| Q2 2023 | $2,823,909 | +83078.5% | 628,933 | -14.0% | 0.00% | -50.0% |
| Q1 2023 | $3,395 | +229.3% | 731,610 | +5.7% | 0.00% | +100.0% |
| Q4 2022 | $1,031 | -100.0% | 691,899 | +18.2% | 0.00% | 0.0% |
| Q3 2022 | $2,195,000 | -12.5% | 585,367 | +15.5% | 0.00% | -50.0% |
| Q2 2022 | $2,509,000 | -27.8% | 506,905 | +19.8% | 0.00% | 0.0% |
| Q1 2022 | $3,473,000 | +190.4% | 423,028 | +256.6% | 0.00% | +100.0% |
| Q4 2021 | $1,196,000 | -63.3% | 118,637 | -42.3% | 0.00% | -50.0% |
| Q3 2021 | $3,256,000 | -46.2% | 205,446 | -19.2% | 0.00% | -50.0% |
| Q2 2021 | $6,048,000 | – | 254,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,670,136 | $26,472,000 | 4.12% |
| Orbimed Advisors | 4,012,281 | $63,595,000 | 0.70% |
| SECTORAL ASSET MANAGEMENT INC | 444,572 | $7,046,000 | 0.59% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 453,012 | $7,180,000 | 0.11% |
| Bellevue Group AG | 507,930 | $8,051,000 | 0.08% |
| JOHNSON & JOHNSON | 55,435 | $879,000 | 0.08% |
| Nantahala Capital Management | 141,641 | $2,245,000 | 0.07% |
| LORD, ABBETT & CO. LLC | 359,421 | $5,697,000 | 0.01% |
| PICTET ASSET MANAGEMENT SA | 569,875 | $9,033,000 | 0.01% |
| Ghisallo Capital Management LLC | 15,000 | $238,000 | 0.01% |